All In MedTech

Device Trial Radar · NCT04486976

Comparative Study of the Cornea/Anterior Segment OCT CASIA2 and the RTVue XR OCT Avanti With AngioVue Software

Last checked: Nov 20, 2026Latest source record: Aug 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 134 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

134

Actual

Start

Jun 27, 2020

Primary completion

Mar 5, 2021

Study completion Mar 5, 2021

Sponsor

Lead sponsor
Tomey CorporationNot on our public-company list
Sponsor type
Industry
First posted
Jul 27, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a prospective comparative, randomized, single center study to gather agreement and precision data in all subjects.

Conditions

  • Glaucoma
  • Cataract

Interventions

  • Cornea/Anterior Segment OCT CASIA2Device

    Cornea/Anterior Segment OCT CASIA2 The Tomey Cornea/Anterior Segment OCT CASIA2 is a non-contact, high resolution tomographic and biomicroscopic device indicated for the in vivo imaging and measurement of ocular structures in the anterior segment, such as corneal thickness. The Tomey Cornea/Anterior Segment OCT CASIA2 is indicated as an aid in the visualization of anterior segment findings.

  • Optovue RTVue XR AvantiDevice

    Optovue RTVue XR Avanti The Avanti is an optical coherence tomography system indicated for the in vivo imaging,axial cross-sectional, and three-dimensional imaging and measurement of anterior and posterior ocular structures.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Agreement of Corneal thickness (μm) measurement for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTTime frame: Up to 30 days
  2. Agreement of Angle-Opening Distance (mm) measurement for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTTime frame: Up to 30 days
  3. Agreement of Trabecular-Iris Space Area measurement (mm²) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTTime frame: Up to 30 days

13 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Andover Eye Associates

    Andover, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.